Santen Pharmaceutical - PDFSEARCH.IO - Document Search Engine

Santen Pharmaceutical
Results: 21

#	Item
1	Microsoft Word - 20160704_Opsiria_India Add to Reading List Source URL: www.santen.com Language: English - Date: 2016-07-01 05:29:33 Medicine Clinical medicine Health Macrolides Immunosuppressants Santen Pharmaceutical Sirolimus Central Drugs Standard Control Organization Intravitreal administration Mechanistic target of rapamycin
2	Santen and University College London to collaborate on ophthalmic research and education 3 August, 2016, Osaka, Japan and London, UK – Santen Pharmaceutical Co., Ltd. (hereinafter, “Santen”) and University College Add to Reading List Source URL: www.santen.com Language: English - Date: 2016-08-01 21:13:14 University of London Santen Pharmaceutical University College London
3	News Release Santen Reports Consolidated Performance for the Fiscal Year Ended March 31, 2015 May 12, 2015 – Santen Pharmaceutical Co., Ltd. (Osaka, JAPAN, Tokyo Stock Exchange CodeSanten) today announced conso Add to Reading List Source URL: www.santen.com Language: English - Date: 2015-05-12 01:37:45
4	News Release Notice of Member of the Board and Corporate Auditors Nominations May 12, Santen Pharmaceutical Co., Ltd. announced today the nominations for the members of the Board of Directors and Corporate Auditor Add to Reading List Source URL: www.santen.com Language: English - Date: 2015-05-12 03:31:02
5	News Release Santen Announces Approval of Ikervis for EU Marketing Authorization March 25, 2015 , Osaka, Japan – Santen Pharmaceutical Co., Ltd. today announced it received approval of the Marketing Authorization Appli Add to Reading List Source URL: www.santen.com Language: English Immunosuppressants Keratitis European Medicines Agency Marketing authorization Keratoconjunctivitis sicca Ciclosporin Health Medicine Pharmaceutical industry
6	News Release Notice of the appointment of Corporate Officers March 10, Santen Pharmaceutical Co., Ltd. announced today the appointment of corporate officers effective from April 1, 2015. Add to Reading List Source URL: www.santen.com Language: English - Date: 2015-03-10 02:37:56 Corporate title Chief executive officer Chief information officer Director Management Corporate governance Titles
7	News Release Santen Announces Proposed Dividends Change March 24, 2015, Osaka, Japan -- Santen Pharmaceutical Co., Ltd. announced that its Board of Directors today approved the change of per-share dividends for the fisca Add to Reading List Source URL: www.santen.com Language: English Finance Equity securities Stock market Dividend Rate of return Share Dividends Financial ratios Financial economics Investment
8	News Release Revision of consolidated earnings forecasts for FY 2014 March 24, 2015, Osaka, Japan -- Santen Pharmaceutical Co., Ltd. announced that it has revised consolidated financial forecasts for fiscal 2014, ending Add to Reading List Source URL: www.santen.com Language: English Net profit Generally Accepted Accounting Principles Financial regulation International Financial Reporting Standards
9	News Release Santen Announces Approval of Glaucoma and Ocular Hypertension Therapeutic, COSOPT Mini Ophthalmic Solution in Japan Osaka, Japan, March 12, 2015Santen Pharmaceutical Co., Ltd. (hereafter Add to Reading List Source URL: www.santen.com Language: English Glaucoma Ethers Alcohols Beta blockers Amines Dorzolamide/timolol Timolol Dorzolamide Merck & Co. Chemistry Medicine Organic chemistry
10	News Release Notice of Change in Significant Shareholder April 10, 2015, Osaka, Japan-- Santen Pharmaceutical Co., Ltd. (“Santen”) announced a change in significant shareholder as of April 2, 2015. １. Details of Ch Add to Reading List Source URL: www.santen.com Language: English - Date: 2015-04-13 04:59:23 Economics Corporate finance Stock Stock market